This company seems to have been delisted
Reason: Acquired by Alfasigma
Last recorded trade on: January 10, 2024
Source: https://www.alfasigma.com/corporate/alfasigma-completes-acquisition-of-intercept-pharmaceuticals-inc/
Reason: Acquired by Alfasigma
Last recorded trade on: January 10, 2024
Source: https://www.alfasigma.com/corporate/alfasigma-completes-acquisition-of-intercept-pharmaceuticals-inc/
Intercept Pharmaceuticals
ICPT
HK$147.75
Share price
0.00%
Change (1 day)
-8.45%
Change (1 year)
Categories
Intercept Pharmaceuticals (ICPT) - Net assets
Net assets on the balance sheet as of September 2023 : HK$0.55 Billion
According to Intercept Pharmaceuticals
's latest financial reports the company has HK$0.55 Billion in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Intercept Pharmaceuticals - Net assets on balance sheet (from 2011 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $HK$0.72 B | -150.7% |
| 2021-12-31 | $-HK$1.44 Billion | 10.9% |
| 2020-12-31 | $-HK$1.3 Billion | -422.14% |
| 2019-12-31 | $HK$0.40 B | 168.03% |
| 2018-12-31 | $HK$0.14 B | 17.01% |
| 2017-12-31 | $HK$0.12 B | -94.76% |
| 2016-12-31 | $HK$2.44 B | -47.67% |
| 2015-12-31 | $HK$4.66 B | 160.6% |
| 2014-12-31 | $HK$1.79 B | 180.26% |
| 2013-12-31 | $HK$0.63 B | 25.08% |
| 2012-12-31 | $HK$0.51 B | -2669.71% |
| 2011-12-31 | $-HK$19.89 Million |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 | HK$110.97 B | 19,764.43% | 🇺🇸 USA |
 | HK$127.43 B | 22,710.22% | 🇺🇸 USA |
 | HK$149.65 B | 26,688.22% | 🇺🇸 USA |
 | HK$0.40 B | -26.92% | 🇺🇸 USA |